Evolent Health (EVH) is in talks with private equity firms and other companies for a potential sale after the company received inbound interest, Milana Vinn and Anirban Sen of Reuters report, citing people familiar with the matter. Private equity firms TPG (TPG) and KKR (KKR.N) are among the parties that have expressed interest in a deal for Evolent, sources told Reuters. Elevance Health (ELV) is also among the bidders and could team up with a private equity firm to acquire Evolent, the sources added. Evolent is working with a financial adviser on the sale process and has received initial bids, the people said. Shares of Evolent Health are up 11% to $31.10 following the report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- 3 Best Stocks to Buy Now, 8/20/2024, According to Top Analysts
- Evolent Health price target raised to $45 from $36 at JPMorgan
- Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz
- Expedia beats, Paramount cuts staff: Friday Buzz
- Expedia reports Q2 beat, Paramount to cut staff: Morning Buzz